We have French content available. View French site.

Snap Chart

Weight-loss Drugs Aren't Just Changing Waistlines

A Bain survey shows GLP-1 drugs, like those known as Ozempic or Wegovy, lead to significant changes in consumer behavior that often persist even after consumers stop taking them.

Par Emily Miller, Sarah Hershey, et Samantha Gorang

Snap Chart

Weight-loss Drugs Aren't Just Changing Waistlines
en

About the Research

Data powered by Dynata, a leading global first-party data and insights platform.

Industry Expertise

Explore Bain's expertise in Consumer Products and learn how we can help your company.

LEARN MORE
First published in décembre 2024
Mots clés

Comment nous avons aidé nos clients

A Consumer Packaged Goods Company Puts Cost and Complexity Reduction at the Heart of Its Transformation

Lire l’étude de cas

Resetting Shared Services to Save $75 Million

Lire l’étude de cas

Digital Drinking in digital: A leading beverage company stirs a profit from digital strategy

Lire l’étude de cas

Vous souhaitez continuer cette conversation ?

Nous aidons des dirigeants du monde entier à matérialiser des impacts et des résultats pérennes et créateurs de valeur dans leurs organisations.

Contacter Bain

Comment pouvons-nous vous aider ?

Voir tous les bureaux